TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
OLMA

Olema Pharmaceuticals Inc

Healthcare · Biotechnology

8.60$ -1.6% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Olema Pharmaceuticals Inc (OLMA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 487 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OLMA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
293 277 264 255 230 451 410 382 352 533 531 487
282 267 252 242 218 438 397 368 334 515 513 470
117 69 34 17 36 139 51 52 35 48 53 49
277 262 249 239 215 434 393 362 329 505 505 461
0.7 0.7 0.7 0.8 0.7 2.1 1.9 2.7 3.0 4.1 3.4 –
4.1 – 2.3 – – – – – – – – –
– – – – – 0.7 0.7 0.8 – – – –
18 23 27 27 31 42 26 37 45 55 50 56
16 22 26 27 31 42 26 33 42 52 47 53
0.9 1.0 1.1 1.1 1.1 1.2 1.0 1.2 1.2 1.1 1.0 0.7
2.2 2.7 7.7 4.4 2.7 4.5 0.2 0.9 3.5 9.3 3.7 1.7
– – – – – – – 3.0 3.0 3.0 3.0 3.0
275 254 236 227 199 409 383 345 307 479 480 431
-279 -306 -337 -367 -402 -435 -465 -509 -551 -598 -651 -714
45 55 56 56 57 59 85 85 86 91 103 104

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?